Ilseong Pharmaceutical, 5.43% Rise Amid COVID-19 (Camostat) Theme Uptrend

On the 18th, the COVID-19 (Camostat) theme rose by 6.89% compared to the previous day, showing strength, while Il Sung Pharmaceutical, a related stock drawing attention, surged by 5.43% compared to the previous day. Il Sung Pharmaceutical is known as a pharmaceutical company that produces penicillin-based antibiotics.

[Graph] Major stock price changes in the COVID-19 (Camostat) theme

According to provisional data compiled at 10:18, foreigners are net selling -54 shares of Il Sung Pharmaceutical.

[Table] Net trading volume by foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Il Sung Pharmaceutical’s quant financial score is 35.82 points, with higher stability and profitability scores than the average of other stocks related to COVID-19 (Camostat), ranking first within the theme. This indicates that, from a financial perspective, Il Sung Pharmaceutical’s ability to respond to internal and external economic environment changes and its efficient profit-generating capability are better compared to other stocks within the theme.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.